» Articles » PMID: 22948837

A Preoperative Nomogram to Predict the Risk of Perioperative Mortality Following Gastric Resections for Malignancy

Overview
Specialty Gastroenterology
Date 2012 Sep 6
PMID 22948837
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Surgery remains one of the major treatment options available to patients with gastric cancer. The aim of this study was to develop a preoperative nomogram based on the presence of comorbidities to predict the risk of perioperative mortality following gastric resections for malignancy.

Methods: The Nationwide Inpatient Sample (NIS) database was used to create a nomogram using SAS software. The training set (years 1993, 1996-97, 1999-2000, 2002, 2004-05) was used to develop the model which was further validated using the validation set (years 1994-95, 1998, 2001, and 2003).

Results: A total of 14,235 and 9,404 patients were included in the training and validation sets, respectively, with overall actual observed perioperative mortality rates of 5.9 % and 6.6 %, respectively. The decile-based calibration plots for the training and validation sets revealed a good agreement between the observed and nomogram-predicted probabilities. The accuracy of the nomogram was further reinforced by a concordance index of 0.75 (95 % confidence interval 0.73 to 0.77) which was calculated using the validation set.

Conclusion: This preoperative nomogram may accurately predict the risk of perioperative mortality following gastric resections for malignancy and may be used as an adjunctive clinical tool in the preoperative counseling of these patients.

Citing Articles

International External Validation of Risk Prediction Model of 90-Day Mortality after Gastrectomy for Cancer Using Machine Learning.

Dal Cero M, Gibert J, Grande L, Gimeno M, Osorio J, Bencivenga M Cancers (Basel). 2024; 16(13).

PMID: 39001525 PMC: 11240515. DOI: 10.3390/cancers16132463.


Preoperative Glutamine Supplementation in Gastric Cancer-Thrombocyte Phagocytic Activity and Early Postoperative Outcomes.

Kamocki Z, Matowicka-Karna J, Jurczuk A, Milewska A, Niewinski A, Zareba K Nutrients. 2023; 15(13).

PMID: 37447236 PMC: 10343864. DOI: 10.3390/nu15132911.


Minimally invasivE versus open total GAstrectomy (MEGA): study protocol for a multicentre randomised controlled trial (DRKS00025765).

Nickel F, Studier-Fischer A, Hausmann D, Klotz R, Vogel-Adigozalov S, Tenckhoff S BMJ Open. 2022; 12(10):e064286.

PMID: 36316075 PMC: 9628650. DOI: 10.1136/bmjopen-2022-064286.


Safety assessment of robotic gastrectomy and analysis of surgical learning process: a multicenter cohort study.

Shimoike N, Nishigori T, Yamashita Y, Kondo M, Manaka D, Kadokawa Y Gastric Cancer. 2022; 25(4):817-826.

PMID: 35416523 DOI: 10.1007/s10120-022-01289-7.


Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis.

van den Boorn H, Engelhardt E, van Kleef J, Sprangers M, van Oijen M, Abu-Hanna A PLoS One. 2018; 13(2):e0192310.

PMID: 29420636 PMC: 5805284. DOI: 10.1371/journal.pone.0192310.


References
1.
Smith B, Stabile B . Gastric adenocarcinoma: reduction of perioperative mortality by avoidance of nontherapeutic laparotomy. J Gastrointest Surg. 2007; 11(2):127-32. DOI: 10.1007/s11605-006-0019-5. View

2.
Smith J, McPhee J, Hill J, Whalen G, Sullivan M, Litwin D . National outcomes after gastric resection for neoplasm. Arch Surg. 2007; 142(4):387-93. DOI: 10.1001/archsurg.142.4.387. View

3.
Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

4.
Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View

5.
Grossmann E, Longo W, Virgo K, Johnson F, Oprian C, Henderson W . Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers. Surgery. 2002; 131(5):484-90. DOI: 10.1067/msy.2002.123806. View